Forbes September 29, 2024
Andrew Wight

Brazilian researchers have topped a bioinformatics competition looking to find already-approved drugs that could function as treatments for Covid-19.

The need for new treatments has not waned: the virus was still the 10th highest cause of death in the US in 2023 according to figures from the Centers for Disease Control and Prevention.

Karina dos Santos Machado, an associate professor at Universidade Federal do Rio Grande in Brazil, led the team that topped a competition help by Canadian nonprofit biotech organization Conscience finding the most molecules that may lead to a new treatment effective against all coronaviruses.

Machado explains that drug discovery can be expensive and long , so re-purposing existing medicines for new uses can streamline this process.

“We...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Healthcare System, Pharma, Pharma / Biotech, Public Health / COVID, Technology
Getting started with AI agents (part 1): Capturing processes, roles and connections
Unlocking The Genetic Code: AI Reveals New Insights Into Psychiatric Disorders
5 questions for the Abundance Institute's Neil Chilson
AI agents are unlike any technology ever
Amazon Increases Total Investment in AI Startup Anthropic to $8 Billion

Share This Article